DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click HERE
to register or log in.
Treatment of Chronic Urinary Salmonella Carriers with Trimethoprim- Sulphamethoxazole
NAVAL MEDICAL RESEARCH UNIT NO 3 FPO NEW YORK 09527
Pagination or Media Count:
Nine chronic urinary salmonella carriers were treated with combined trimethoprim-sulphamethoxazole and niridazole and another 10 carriers used as controls were treated with niridazole. Eight of nine who received combined therapy were completely cured whereas only three of the 10 receiving antischistosomal therapy alone were cured. Of the seven patients who relapsed after antischistosomal therapy five were successfully re-treated with trimethoprim-sulphamethoxazole.
APPROVED FOR PUBLIC RELEASE